Get Live Data

Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in CanadaView Video
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. OptiBiotix Health Share Price
  4. OptiBiotix Health Share News
  5. OptiBiotix appoints CEO Stephen O'Hara as CEO of subsidiary

Pin to quick picksOptiBiotix Health Share News (OPTI)

OptiBiotix Health Information

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.50
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 1.00 (5.714%)
Open: 18.00
High: 18.00
Low: 18.00
Prev. Close: 18.00
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OptiBiotix appoints CEO Stephen O'Hara as CEO of subsidiary

Tue, 21st Feb 2023 14:15

(Alliance News) - OptiBiotix Health PLC on Tuesday said that Rene Kamminga, Chief Executive Officer of subsidiary OptiBiotix Ltd, will leave the business next week Tuesday.

The York, England-based probiotics developer tackling obesity, cardiovascular diseases and lifestyle conditions announced it appointed its CEO Stephen O'Hara as CEO of the subsidiary.

O'Hara "will lead a minor restructuring of the business," OptiBiotix added.

Optibiotix shares were 2.8% lower at 12.89 pence each in London on Tuesday afternoon.

By Tom Budszus, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
17 Feb 2020 09:09

OptiBiotix Health signs North American distribution agreement for LPLDL

(Sharecast News) - Life sciences business OptiBiotix Health has inked a distribution agreement with Advanced NutriSolutions/Select Ingredient for the exclusive sale of its patented probiotic strain LPLDL in the United States and Canada.

Read more
12 Feb 2020 10:40

OptiBiotix Health Inks Licencing Deal For Yoghurt With LPLDL Probiotic

OptiBiotix Health Inks Licencing Deal For Yoghurt With LPLDL Probiotic

Read more
12 Feb 2020 09:11

OptiBiotix strikes deal for proprietary probiotic yoghurt

(Sharecast News) - Life sciences business OptiBiotix Health announced on Wednesday that its wholly-owned subsidiary ProBiotix Health has signed a licencing agreement with Granja Pocha for the inclusion of its patented probiotic strain, 'LPLDL', into a functional yoghurt product in Uruguay.

Read more
31 Jan 2020 15:29

OptiBiotix, Agropur Launch SlimBiome Product In North America

OptiBiotix, Agropur Launch SlimBiome Product In North America

Read more
31 Jan 2020 08:57

OptiBiotix and partner Agropur launch 'SlimBiome' in North America

(Sharecast News) - Life sciences company OptiBiotix Health and its partner Agropur announced the launch of 'SlimBiome' in the North American market on Friday.

Read more
28 Jan 2020 13:02

OptiBiotix Health Expands SlimBiome And GoFigure Distribution Deals

OptiBiotix Health Expands SlimBiome And GoFigure Distribution Deals

Read more
27 Jan 2020 09:50

AlfaSigma To Launch New Supplement Containing OptiBiotix Probiotic

AlfaSigma To Launch New Supplement Containing OptiBiotix Probiotic

Read more
17 Jan 2020 10:32

OptiBiotix Health Aims For Profit In 2020; Explores Nasdaq Listing

OptiBiotix Health Aims For Profit In 2020; Explores Nasdaq Listing

Read more
17 Jan 2020 08:08

OptiBiotix eyes profitability in 2020, explores Nasdaq listing

(Sharecast News) - Life sciences business OptiBiotix Health provided revenue guidance for its recently wrapped up trading year on Friday and told investors it was now eyeing up a dual-listing on the New York Stock Exchange as it forecast profitability in 2020.

Read more
8 Jan 2020 15:56

OptiBiotix Health reports successful results from hypertension study

(Sharecast News) - Life sciences business OptiBiotix Health announced on Wednesday that its fully-owned subsidiary ProBiotix Health, in partnership with Nutrilinea, has completed a successful human study for a new food supplement formulation containing 'LPLDL', and showed that the product could reduce high blood pressure, or hypertension.

Read more
8 Jan 2020 10:42

OptiBiotix Health's LPLDL Product Reduces Hypertension In Study

OptiBiotix Health's LPLDL Product Reduces Hypertension In Study

Read more
7 Jan 2020 08:58

Holland & Barrett Launching Product Containing OptiBiotix's SlimBiome

Holland & Barrett Launching Product Containing OptiBiotix's SlimBiome

Read more
19 Dec 2019 12:25

OptiBiotix Inks New SlimBiome Distribution Deal In Germany

OptiBiotix Inks New SlimBiome Distribution Deal In Germany

Read more
17 Dec 2019 13:44

OptiBiotix Health launches two products with partners in India

(Sharecast News) - Life sciences company OptiBiotix Health announced the commercial launch of two products formulated with its 'SlimBiome' product in the Indian market on Tuesday, in partnership with Anthem BioPharma and Zeon Life Sciences.

Read more
17 Dec 2019 12:25

OptiBiotix Health Launches Two SlimBiome-Based Products In India

OptiBiotix Health Launches Two SlimBiome-Based Products In India

Read more
67891011121314

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.